94 related articles for article (PubMed ID: 18475244)
1. Comparison of lentiviral and adenoviral gene therapy for spinal fusion in rats.
Miyazaki M; Sugiyama O; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Virk MS; Lieberman JR; Wang JC
Spine (Phila Pa 1976); 2008 Jun; 33(13):1410-7. PubMed ID: 18475244
[TBL] [Abstract][Full Text] [Related]
2. Binding to COMP Reduces the BMP2 Dose for Spinal Fusion in a Rat Model.
Refaat M; Klineberg EO; Fong MC; Garcia TC; Leach JK; Haudenschild DR
Spine (Phila Pa 1976); 2016 Jul; 41(14):E829-E836. PubMed ID: 26679888
[TBL] [Abstract][Full Text] [Related]
3. Sex-based Difference in Response to Recombinant Human Bone Morphogenetic Protein-2 in a Rat Posterolateral Fusion Model.
Foley JP; Fred EJ; Minardi S; Yamaguchi JT; Greene AC; Furman AA; Lyons JG; Paul JT; Nandurkar TS; Blank KR; Havey RM; Muriuki M; Patwardhan AG; Hsu WK; Stock SR; Hsu EL
Spine (Phila Pa 1976); 2022 Dec; 47(23):1627-1636. PubMed ID: 35943241
[TBL] [Abstract][Full Text] [Related]
4. Safety assessment of intradiscal gene therapy II: effect of dosing and vector choice.
Levicoff EA; Kim JS; Sobajima S; Wallach CJ; Larson JW; Robbins PD; Xiao X; Juan L; Vadala G; Gilbertson LG; Kang JD
Spine (Phila Pa 1976); 2008 Jun; 33(14):1509-16; discussion 1517. PubMed ID: 18520636
[TBL] [Abstract][Full Text] [Related]
5. The bone morphogenetic protein 2 analogue L51P enhances spinal fusion in combination with BMP2 in an in vivo rat tail model.
Gantenbein B; Oswald KAC; Erbach GF; Croft AS; Bermudez-Lekerika P; Strunz F; Bigdon SF; Albers CE
Acta Biomater; 2024 Mar; 177():148-156. PubMed ID: 38325708
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution of lentiviral transduced adipose-derived stem cells for "ex-vivo" regional gene therapy for bone repair.
Bell JA; Collon K; Mayfield C; Gallo MC; Chang SW; Sugiyama O; Tang AH; Hollis R; Chopra S; Kohn DB; Lieberman JR
Gene Ther; 2023 Dec; 30(12):826-834. PubMed ID: 37568039
[TBL] [Abstract][Full Text] [Related]
7. A supramolecular polymer-collagen microparticle slurry for bone regeneration with minimal growth factor.
McClendon MT; Ji W; Greene AC; Sai H; Sangji MH; Sather NA; Chen CH; Lee SS; Katchko K; Jeong SS; Kannan A; Weiner J; Cook R; Driscoll A; Lubbe R; Chang K; Haleem M; Chen F; Qiu R; Chun D; Stock SR; Hsu WK; Hsu EL; Stupp SI
Biomaterials; 2023 Nov; 302():122357. PubMed ID: 37879188
[TBL] [Abstract][Full Text] [Related]
8. Live cell imaging of primary rat neonatal cardiomyocytes following adenoviral and lentiviral transduction using confocal spinning disk microscopy.
Sakurai T; Lanahan A; Woolls MJ; Li N; Tirziu D; Murakami M
J Vis Exp; 2014 Jun; (88):e51666. PubMed ID: 24998400
[TBL] [Abstract][Full Text] [Related]
9. Optimal Intermittent Administration Interval of Abaloparatide for Bone Morphogenetic Protein-Induced Bone Formation in a Rat Spinal Fusion Model.
Abe T; Miyazaki M; Sako N; Kanezaki S; Tsubouchi Y; Kaku N
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612467
[TBL] [Abstract][Full Text] [Related]
10. Delivery of Growth Factors to Enhance Bone Repair.
Ball JR; Shelby T; Hernandez F; Mayfield CK; Lieberman JR
Bioengineering (Basel); 2023 Oct; 10(11):. PubMed ID: 38002376
[TBL] [Abstract][Full Text] [Related]
11. Optimal intermittent administration interval of parathyroid hormone 1-34 for bone morphogenetic protein-induced bone formation in a rat spinal fusion model.
Abe T; Miyazaki M; Ishihara T; Kanezaki S; Tsubouchi Y; Tsumura H
JOR Spine; 2021 Sep; 4(3):e1168. PubMed ID: 34611590
[TBL] [Abstract][Full Text] [Related]
12. 3D-Printed Ceramic-Demineralized Bone Matrix Hyperelastic Bone Composite Scaffolds for Spinal Fusion.
Driscoll JA; Lubbe R; Jakus AE; Chang K; Haleem M; Yun C; Singh G; Schneider AD; Katchko KM; Soriano C; Newton M; Maerz T; Li X; Baker K; Hsu WK; Shah RN; Stock SR; Hsu EL
Tissue Eng Part A; 2020 Feb; 26(3-4):157-166. PubMed ID: 31469055
[TBL] [Abstract][Full Text] [Related]
13. The role of transduced bone marrow cells overexpressing BMP-2 in healing critical-sized defects in a mouse femur.
Pensak M; Hong S; Dukas A; Tinsley B; Drissi H; Tang A; Cote M; Sugiyama O; Lichtler A; Rowe D; Lieberman JR
Gene Ther; 2015 Jun; 22(6):467-75. PubMed ID: 25809463
[TBL] [Abstract][Full Text] [Related]
14. Spinal fusion in the next generation: gene and cell therapy approaches.
Barba M; Cicione C; Bernardini C; Campana V; Pagano E; Michetti F; Logroscino G; Lattanzi W
ScientificWorldJournal; 2014; 2014():406159. PubMed ID: 24672316
[TBL] [Abstract][Full Text] [Related]
15. Micro-computed tomography-based three-dimensional kinematic analysis during lateral bending for spinal fusion assessment in a rat posterolateral lumbar fusion model.
Yamaguchi T; Inoue N; Sah RL; Lee YP; Taborek AP; Williams GM; Moseley TA; Bae WC; Masuda K
Tissue Eng Part C Methods; 2014 Jul; 20(7):578-87. PubMed ID: 24199634
[TBL] [Abstract][Full Text] [Related]
16. Gene delivery to bone.
Evans CH
Adv Drug Deliv Rev; 2012 Sep; 64(12):1331-40. PubMed ID: 22480730
[TBL] [Abstract][Full Text] [Related]
17. Strategies for controlled delivery of growth factors and cells for bone regeneration.
Vo TN; Kasper FK; Mikos AG
Adv Drug Deliv Rev; 2012 Sep; 64(12):1292-309. PubMed ID: 22342771
[TBL] [Abstract][Full Text] [Related]
18. LvBMP-2 gene-modified BMSCs combined with calcium phosphate cement scaffolds for the repair of calvarial defects in rats.
Zhu C; Chang Q; Zou D; Zhang W; Wang S; Zhao J; Yu W; Zhang X; Zhang Z; Jiang X
J Mater Sci Mater Med; 2011 Aug; 22(8):1965-73. PubMed ID: 21681654
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
